Hester Biosciences Q2 Results
- BSE: 524669
- NSE: HESTERBIO
- ISIN: INE782E01017
- Sector: Biotechnology & Drugs
BSE
2,066.00
-3.50 (-0.17%)
-3.50 (-0.17%)Volume1.30 K
Updated: Tue 16 Jun, 2026 | 15:29:32
NSE
2,065.00-1.60 (-0.08%)
-1.60 (-0.08%)Volume5.74 K
Updated: Tue 16 Jun, 2026 | 15:29:43
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Hester Biosciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 63.61 | 65.47 | -2.85% | 68.73 | -7.46% |
| Depreciation/ Amortization | 4.35 | 4.18 | 4.11% | 4.20 | 3.64% |
| Operating Income | 7.36 | 18.63 | -60.48% | 14.96 | -50.77% |
| Net Income | 14.45 | 16.44 | -12.12% | 8.20 | 76.23% |
| Other Operating Expenses Total | 24.43 | 23.55 | 3.75% | 24.12 | 1.29% |
| Net Income Before Taxes | 17.04 | 20.19 | -15.61% | 11.87 | 43.55% |
| Total Revenue | 70.97 | 84.10 | -15.62% | 83.69 | -15.20% |
| Selling/ General/ Admin Expenses Total | 15.50 | 15.28 | 1.43% | 15.90 | -2.48% |
| Diluted Normalized EPS | 16.85 | 8.54 | 97.31% | 9.86 | 70.89% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.